Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mineralys Therapeutics, Inc.

13.94
+0.38002.80%
Pre-market: 13.37-0.5700-4.09%04:24 EDT
Volume:458.47K
Turnover:6.30M
Market Cap:904.37M
PE:-3.81
High:13.96
Open:13.47
Low:13.06
Close:13.56
Loading ...
Apr 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]